Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Alain Romero
The ultimate luxury: how cultivated tropical hardwoods are becoming nature's most coveted asset
Nature's scarcest resource In the realm of luxury assets, a new scarcity surpasses even the rarity of diamonds. Premium tropical hardwoods, traditionally the material of kings and craftsmen, face an unprecedented biological bottleneck. According to the Global Forest Resources Assessment, of our world's estimated 3 trillion trees, only 800 billion exist in tropical regions, and less than 1% are commercial hardwood species. This scarcity isn't merely market-driven; it's fundamentally biological.
Trees as hedge investments
In an era of economic volatility and environmental crisis, investors are increasingly looking for stable, sustainable assets that can weather market storms while contributing to positive change. Enter the world of tree investments – a growing sector that promises financial returns alongside significant environmental and social benefits. The rise of tree investments Trees have long been recognized as valuable assets, traditionally through large-scale timber investments.
Revolutionizing impact investment in tropical hardwood restoration
Introduction: Traditionally, forestry investment has been the domain of large-scale operations or institutional investors. However, Forests to Fortune, in collaboration with mission-driven foundations and endowments, has created an innovative business model that democratizes access to this asset class while prioritizing environmental conservation and social development.
Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
Summary Background Spironolactone is effective at reducing blood pressure in patients with uncontrolled resistant hypertension. However, the use of spironolactone in patients with chronic kidney disease can be restricted by hyperkalaemia. We evaluated use of the potassium binder patiromer to allow more persistent use of spironolactone in patients with chronic kidney disease and resistant hypertension.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Alain
Contact Alain, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack